Reneuron Share Price (RENE)

And thank you Quady. I too hope your source is correct and for the same reasons. Could be an interesting week with potential news to come on several fronts. A useful exchange of information and worth checking Renes web site for updates. Best wishes. Freddie

Good afternoon , thank you for the info , The thing I have learnt over the years is their is many ways or representing the same info . Sometimes its presented in a good way , sometimes its rotten . I did notice this myself , but would say that looking at my link below its dated the 7th June 2013 , the website states at the bottom , that it was last updated 15th May 2013 at 15.45 , also if my info is correct ( not saying it is ) Then this is encouraging as looks like the major investors have up'ed their stake . Must admit to some disbelief on this point , as this would have occured over less than one month and as such , does not explain the fall in the price. However in saying that on 28th May , the share price jumped , so maybe some buying going on here , would love some comments on how many shares in the free float .

Quady. I was under the impression that John Sinden holds very little stock. My source is Reneuron web site which reads as follows_ ''The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 3,417,006 ordinary shares in the Company, representing 0.44% of the Company's current issued share capital''. If I am correct I am wondering if your source is referring to share options as against actual director holdings. Interestingly enough when you look at the option to buy price that directors will eventually be able to purchase at (based on goal post being achieved) the price is way higher than the current sp. All in all a pretty painful situation for all involved in previous investing with great prospects ahead and in my opinion plenty of topside opportunities for shrewd investors entering now. Best wishes and dyor of course. Freddie

Ok , just done a bit of delveing , will not comment , just present info , and source . Board: Chairman: Bryan Morton (0% holding) Chief Executive: Michael Hunt (.1% holding) Chief Scientific Officer: John Sinden (.7% holding) The main shareholders are : Excalibur Fund Managers: 11.9% Toscafund Asset Management: 10.8% Saad Investments: 6.9% Majedie Asset Management: 5.3% Charles Good: 5.1% My source is http://www.growthcompany.co.uk/company-profiles/r/1028882/reneuron.thtml

Morning SciFi , My knowledge is in commodities and tech , so unable to give an experienced view on this company. My interest is that this poped up on my horizon , a while ago while the price was higher , and the broker reviews were favorable . Although the value of a share is in the supply and demand of the company itself , their needs to be a healthy daily trade in the pool of shares on the market . Acompanied by one or two institutional investors , who are in for the long term , in order to provide a smaller pool of shares to trade . Its not easy to say what the ratio should be as have got this type of calculation wrong more often than right , but would be interested if any investors are sniffing around this share , or indeed what the split on the holdings are , possibly someone on this forum has attended shareholder meetings , as they often give a split or institutional investors and private investors . Also at this stage would be interested to know , to what extent the CEO and directors have invested themselves . Not always a good indication , but shows some confidence , especially if they are now buying at these levels . If I can get this type of info and its verifiable , then very tempted to have a punt as quite rightly the tech info is going to be classified and at the best rumour . Not interested in heresay. So would be grateful if anyone has this info .

Well I don't expect any hard facts unless the source is from Glasgow or the catapult. I met these guys at a medical conference a few years ago and they were smarting from some of the "stick" they were getting from shareholders who bought in the bubble pre-dilution and saw their money fractionalised. For me, now, (I'm in at 2.51p) its about whether they get from 2.5p (cap 20 M) to somewhere near 9p. The question for me is: would they get to that value in the medium term if the next trial results are positive (is it July?) Are they worth cap75 M when they succeed.? Experienced view please (I'm not experienced investor, and we've heard the rampers) or can I borrow a crystal ball, please. :-)